| Association of image‐defined risk factors with clinical features, histopathology, and outcomes in neuroblastoma WC Temple, KT Vo, KK Matthay, B Balliu, C Coleman, J Michlitsch, ... Cancer medicine 10 (7), 2232-2241, 2021 | 33 | 2021 |
| Incorporating radiomics into machine learning models to predict outcomes of neuroblastoma G Liu, M Poon, MA Zapala, WC Temple, KT Vo, KK Matthay, D Mitra, ... Journal of Digital Imaging 35 (3), 605-612, 2022 | 21 | 2022 |
| Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children’s Oncology Group W Temple, L Mendelsohn, GE Kim, E Nekritz, WC Gustafson, L Lin, ... European journal of nuclear medicine and molecular imaging 43, 474-481, 2016 | 21 | 2016 |
| Diagnosis and management of lymphoblastic lymphoma in children, adolescents and young adults WC Temple, S Mueller, ML Hermiston, B Burkhardt Best Practice & Research Clinical Haematology 36 (1), 101449, 2023 | 13 | 2023 |
| Maternal high-protein and low-protein diets perturb hypothalamus and liver transcriptome and metabolic homeostasis in adult mouse offspring LJ Martin, Q Meng, M Blencowe, S Lagarrigue, S Xiao, C Pan, J Wier, ... Frontiers in Genetics 9, 642, 2018 | 12 | 2018 |
| Framework humanization optimizes potency of anti-CD72 nanobody CAR-T cells for B-cell malignancies WC Temple, MA Nix, A Naik, A Izgutdina, BJ Huang, G Wicaksono, ... Journal for Immunotherapy of Cancer 11 (11), 2023 | 4 | 2023 |
| Structural surfaceomics reveals an AML-specific conformation of integrin β2 as a CAR T cellular therapy target K Mandal, G Wicaksono, C Yu, JJ Adams, MR Hoopmann, WC Temple, ... Nature Cancer 4 (11), 1592-1609, 2023 | 3 | 2023 |
| Structural surfaceomics reveals an AML-specific conformation of integrin-β2 as an immunotherapeutic target K Mandal, G Wicaksono, C Yu, JJ Adams, MR Hoopmann, WC Temple, ... Blood 140 (Supplement 1), 867-868, 2022 | 3 | 2022 |
| Pre‐and post‐HSCT use of TKI therapy for fusion‐driven B‐ALL: A case series of five pediatric, adolescent and young adult patients SS Shumock, WC Temple, A Marinoff, K Aaronson, E Southworth, ... Cancer Reports 6 (12), e1901, 2023 | 2 | 2023 |
| Affinity matured CD72 CAR-T improves efficacy versus low antigen density B-cell non-hodgkin lymphoma models A Izgutdina, WC Temple, MA Nix, H Geng, E Ramos, A Naik, R Larson, ... Blood 142, 2068, 2023 | 1 | 2023 |
| Humanized Nanobody Anti-CD72 CAR-T Cells Efficiently Eliminate B-Cell Malignancies Via Improved Affinity for CD72 but Induce Persistent Antigen Downregulation In Vivo WC Temple, G Wicaksono, A Naik, A Izgutdina, MA Nix, E Young, ... Blood 140 (Supplement 1), 7394-7395, 2022 | 1 | 2022 |
| Structural surfaceomics reveals an AML-specific conformation of Integrin-β2 as a CAR-T therapy target K Mandal, G Wicaksono, C Yu, JJ Adams, MR Hoopmann, WC Temple, ... bioRxiv, 2022.10. 10.511511, 2022 | 1 | 2022 |
| CD72 Nanobody-Based CAR-T Cells Have Potent Anti-Tumor Efficacy in B Cell Malignancies MA Nix, WC Temple, W Karlon, D Wang, P Phojanakong, V Steri, B Hann, ... Blood 138, 1717, 2021 | 1 | 2021 |
| Preclinical Development and Characterization of Humanized Anti-CD72 Nanobody Chimeric Antigen Receptor T Cells for B Cell Malignancies WC Temple, A Izgutdina, MA Nix, BJ Huang, P Phojanakong, ... Transplantation and Cellular Therapy, Official Publication of the American …, 2024 | | 2024 |
| CD72 NANOBODY CAR-T CELLS HAVE POTENT ANTITUMOR EFFICACY IN B CELL MALIGNANCIES W Temple, M Nix, G Wicaksono, D Wang, P Phojanakong, V Steri, B Hann, ... Leukemia Research 121, S8, 2022 | | 2022 |
| Vesicular monoamine transporter protein expression in neuroblastoma: A report from the Children’s Oncology Group. SG DuBois, W Temple, L Mendelsohn, GE Kim, E Nekritz, C Gustafson, ... Journal of Clinical Oncology 33 (15_suppl), 10043-10043, 2015 | | 2015 |
